Acadia Pharmaceuticals | ACAD - Capital De Préstamo





Capital De Préstamo Cambio Fecha
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 1.48B 7.23M 2026-06
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Biogen USD 7.29B 1B 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Cara Therapeutics USD 0 0 2025-03
Cytokinetics USD 248.2M 993K 2026-06
Eisai JPY 184.6B 49.83B 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Incyte USD 28.42M 994K 2026-06
J&J USD 37.34B 183M 2026-06
Moderna USD 597M 6M 2026-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 60.5B 70M 2026-06
Prothena USD 0 0 2024-12
PTC Therapeutics USD 535.52M 248.58M 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12